scholarly article | Q13442814 |
P356 | DOI | 10.1182/BLOOD-2002-08-2482 |
P953 | full work available at URL | http://www.bloodjournal.org/content/102/4/1443.full.pdf |
http://ashpublications.org/blood/article-pdf/102/4/1443/1689933/h81603001443.pdf | ||
P698 | PubMed publication ID | 12738680 |
P5875 | ResearchGate publication ID | 10766790 |
P50 | author | Ronald Levy | Q1758880 |
Izidore S Lossos | Q89690678 | ||
P2093 | author name string | Takashi Akasaka | |
P2860 | cites work | Histologic conversion in the non-Hodgkin's lymphomas | Q70325819 |
The natural history of initially untreated low-grade non-Hodgkin's lymphomas | Q70817025 | ||
Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement | Q71248576 | ||
Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene | Q73399558 | ||
Genetic instability is associated with histological transformation of follicle center lymphoma | Q73462104 | ||
Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphoma | Q74540287 | ||
Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics | Q78427236 | ||
Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma | Q24561494 | ||
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas | Q28207345 | ||
LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas | Q28255448 | ||
Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma | Q28256118 | ||
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells | Q28294137 | ||
Disruption of the Bcl6 gene results in an impaired germinal center formation | Q28509600 | ||
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation | Q28584806 | ||
Control of inflammation, cytokine expression, and germinal center formation by BCL-6 | Q28585541 | ||
Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma | Q30449832 | ||
Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes | Q34066202 | ||
Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. | Q37626496 | ||
BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5' regulatory region of the BCL-6 gene | Q38363486 | ||
Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation | Q41127074 | ||
Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21). | Q41422880 | ||
Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms | Q41646099 | ||
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. | Q46038765 | ||
Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets | Q48040877 | ||
Chromosomal translocations in human cancer. | Q52512616 | ||
Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma. | Q53553696 | ||
p53 mutation in B-cell lymphoid neoplasms with reference to oncogene rearrangements associated with chromosomal translocations. | Q54964052 | ||
Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer | Q68918964 | ||
Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas | Q69406382 | ||
Involvement of the bcl-2 gene in human follicular lymphoma | Q69870224 | ||
Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression | Q69948335 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biochemistry | Q7094 |
cell biology | Q7141 | ||
immunology | Q101929 | ||
follicular lymphoma | Q123251 | ||
lymphoma | Q208414 | ||
P304 | page(s) | 1443-1448 | |
P577 | publication date | 2003-05-08 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma | |
P478 | volume | 102 |
Q90171124 | A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era |
Q38576194 | A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements |
Q81760666 | A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma |
Q48847317 | A unique subtype of diffuse large B-cell lymphoma primarily involving the bone marrow, spleen, and liver, defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography |
Q38798801 | Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas |
Q47269833 | BCL6 as a therapeutic target for lymphoma |
Q37119576 | BCL6 expression correlates with monomorphic histology in children with posttransplantation lymphoproliferative disease |
Q58001496 | C-MYCtranslocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator? |
Q36225164 | Cell of origin of transformed follicular lymphoma |
Q81045171 | Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma |
Q36562212 | Clinical and molecular prognostic factors in follicular lymphoma |
Q37944927 | Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma |
Q35234867 | Control of asymmetric Hopfield networks and application to cancer attractors |
Q48185856 | Current prognostic and predictive factors in follicular lymphoma |
Q64077615 | DSB structure impacts DNA recombination leading to class switching and chromosomal translocations in human B cells |
Q30478009 | Differential prioritization between relevance and redundancy in correlation-based feature selection techniques for multiclass gene expression data |
Q50694815 | Discovery of microRNA-mRNA modules via population-based probabilistic learning. |
Q28071905 | Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma |
Q55011560 | Epigenomic Modifications Mediating Antibody Maturation. |
Q37417536 | Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary Care Institute in Southern India |
Q95589298 | Follicular lymphoma |
Q44035879 | Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients |
Q50107045 | From genetics to the clinic: a translational perspective on follicular lymphoma. |
Q53350377 | Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasms. |
Q48186152 | Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia |
Q57493686 | Generation and characteristics of a novel "double-hit" high grade B-cell lymphoma cell line DH-My6 with / and / gene arrangements and potential molecular targeted therapies |
Q33910446 | Genetics of follicular lymphoma transformation |
Q53675188 | Higher-grade transformation of follicular lymphoma -- a continuous enigma. |
Q46476524 | Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms |
Q34353406 | Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells |
Q54561742 | Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. |
Q24685920 | Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition |
Q33558757 | Nature and importance of follicular lymphoma precursors |
Q42624362 | Neoplastic MiR-17~92 deregulation at a DNA fragility motif (SIDD). |
Q84289348 | Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2 |
Q36290288 | Pathogenesis of follicular lymphoma |
Q82717691 | Prognosis of follicular lymphomas |
Q47731613 | Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics. |
Q82951269 | Role of activation-induced cytidine deaminase in the progression of follicular lymphoma |
Q33866835 | Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease |
Q43186206 | The small GTPase RhoH is an atypical regulator of haematopoietic cells |
Q40683450 | The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era. |
Q35038729 | Transformation of follicular lymphoma |
Q36869113 | Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms |
Q47771789 | Transformed follicular lymphoma. |
Q83162393 | Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology |
Q33299950 | Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering |
Search more.